Best IVF and Fertility Clinics in Lithuania

Find the best IVF and fertility clinic in Lithuania for you. Compare patient reviews, treatment options and IVF costs in Lithuania.

IVF age limits and treatment requirements in Lithuania

April 2026 Health Insurance Fund guidance explains the Constitutional Court ruling on marriage and partnership restrictions and the pending reform. It states that the existing service-recipient group continues until the amending law is adopted. Confirm subsequent changes and the specific single-woman or female-couple route; do not treat the proposal as enacted access.

Check IVF laws in Lithuania
Age limits
Procedure-specific age assessment
Patient eligibility
Eligibility depends on the treatment pathway
Donor identity
Confirm the donor-information framework
Foreign patients
Confirm access with provider

IVF success rates in Lithuania

Explore national outcomes for donor eggs, frozen embryo transfers and fresh IVF or ICSI. Find your age group and treatment, and compare with the EU reference where equivalent data are available.

National clinical pregnancy rates · Treatment year 2020

Donor eggs2020 · Clinical pregnancies per 100 embryo transfers
Recipient ageCountryEU median
<34 years100.0%45.7%
35–39 years100.0%45.5%
40+ years100.0%41.7%

Age of the recipient · donor treatment combined
EU median: 16 reporting EU countries

Frozen embryo transfer2020 · Clinical pregnancies per 100 thawing cycles
Age groupCountryEU median
<34 years33.0%38.8%
35–39 years36.4%32.8%
40+ years50.0%27.9%

Own eggs · frozen IVF / ICSI embryos
EU median: 18 reporting EU countries

Fresh ICSI2020 · Clinical pregnancies per 100 egg collections
Age groupCountryEU median
<34 years35.4%25.6%
35–39 years28.3%20.2%
40+ years3.8%10.1%

Own eggs · fresh ICSI treatment
EU median: 19 reporting EU countries

Each table measures a different treatment stage: transfer, thawing or egg collection. Compare the same treatment and age group across countries.

The EU reference is the median of available EU-27 country rates for the same treatment, age band and year (2020). Each country has equal weight. It describes the middle country result, not the pooled success rate of all EU patients.

Source: ESHRE / European IVF Monitoring

About these statistics

These are clinical pregnancy rates, rather than birth rates or the cumulative chance of a baby from a full course of treatment. The 2020 reporting year was affected by the pandemic. Patient populations, registry coverage and reporting completeness differ between countries.

Age bands follow the source labels: <34, 35–39 and 40+. The source does not clarify the boundary for age 34. Donor results use recipient age and combine donor treatment variants. Age-specific cohort sizes and separate donor transfer variants are not provided in these tables. “Not published” means this report provides no corresponding age-specific rate.

EU-27 membership is used for the benchmark. Missing country rates are omitted, never counted as zero. Non-EU reporting countries are excluded from the reference. Country rates are descriptive; differences do not establish clinic quality or a personal prognosis.

Donor eggs: S12, E27:G27 · Frozen embryo transfer: S11, E28:G28 · Fresh ICSI: S10, E28:G28 · Reviewed 2026-10-15

Questions to ask your clinic
  • What are your clinical pregnancy and birth outcomes for patients of my age using the same egg source?
  • Is the rate per started cycle, per egg collection, per thawing cycle or per transfer?
  • Which treatment years and how many cases are included, and how do you account for missing follow-up?
  • How do you follow up outcomes for patients who return to another country?

Compare IVF success rates by country

Popular Destinations in Lithuania

Explore popular cities and regions in Lithuania.

Frequently Asked Questions

Common questions about IVF in Lithuania.

Procedure-specific age assessment. This guide does not establish a numerical upper limit for every IVF method. Ask the authorised provider for its own-egg, donor-egg and embryo-transfer cut-offs. Domestic insurance and public-programme entitlement must be assessed separately from private treatment and foreign-patient access.